• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

4563:JP

379.0 JPY 3.0 0.80%

As of 19:30:43 ET on 12/18/2014.

Snapshot for AnGes MG Inc (4563)

Open: 380.0 Day's Range: 377.0 - 385.0 Volume: 375,100
Previous Close: 376.0 52wk Range: 232.0 - 635.9 1-Yr Rtn: -23.45%

Stock Chart for 4563

No chart data available.
  • 4563:JP 379.0
  • 1D
  • 1M
  • 1Y
376.0
Interactive 4563 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4563

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -69.4837
Est. EPS (JPY) (12/2014) -63.2500
Est. PEG Ratio -
Market Cap (M JPY) 20,132.68
Shares Outstanding (M) 53.54
30 Day Average Volume 1,202,273
Price/Book (mrq) 2.5469
Price/Sale (ttm) 36.4290
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4563

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4563

AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.

Ei YamadaPresident/CEO
More Company Profile & Key Executives for 4563

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil